NBY 8-K 2026-01-16

NovaBay Pharmaceuticals, Inc. (NBY) 8-K dated 2026-01-16 — accession 0001437749-26-001459. This URL is the filing, not the NBY hub.

NovaBay Pharmaceuticals, Inc. (NBY) is a biotechnology company listed on US.

NovaBay Pharmaceuticals, Inc. filed a 8-K on 2026-01-16. Accession 0001437749-26-001459.

Cached items: 1.01, 3.02, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NBY revenue for 2026-06-30 was $2.2M. Net income was -$41.1M. Revenue was down 10.4% from 2026-03-31 to 2026-06-30. NBY currently screens at market cap $51.9M.

Not investment advice. The NBY SEC hub lists recent forms. The stock page is the research view.